| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |